RGS17
MOLECULAR TARGETregulator of G protein signaling 17
RGS17 (regulator of G protein signaling 17) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting RGS17
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gambogic acid | 3.69 | 39 |
| 2 | sanguinarium | 3.40 | 29 |
| 3 | sanguinarium chloride | 2.56 | 12 |
| 4 | celastrol | 1.95 | 6 |
About RGS17 as a Drug Target
RGS17 (regulator of G protein signaling 17) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented RGS17 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
RGS17 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.